Bluezone to enter life insurance industry amid £1.5m funding

The funding round was led by Insurtech Gateway and AV8 Ventures, and included investors Oxford Capital, Portfolio Ventures and the chief executive of AXA, chief transformation officer at Aegon Group and the former chairman of NHS England. The start-up insurtech plans to use the investment to expand its team and launch its first product, a Type 2 Diabetes life insurance product. Bluezone aims to "reinvent" traditional underwriting processes which are often "outdated, manual and cumbersome" and ultimately makes it difficult for individuals with chronic conditions to access insurance. ...